The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations.
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001923:Brain Chemistry / Q000187:drug effects*; D004347:Drug Interactions; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism*; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D008297:Male; D011804:Quinolines / Q000494:pharmacology*; D011814:Quipazine / Q000494:pharmacology*; D051381:Rats; D011985:Receptors, Serotonin / Q000187:drug effects*
D014150:Antipsychotic Agents; D011804:Quinolines; D011985:Receptors, Serotonin; D011814:Quipazine; D006897:Hydroxyindoleacetic Acid; D008238:Lysergic Acid Diethylamide